127 related articles for article (PubMed ID: 8823450)
1. Sources and sequelae of bacterial contamination of hematopoietic stem cell components: implications for the safety of hematotherapy and graft engineering.
Webb IJ; Coral FS; Andersen JW; Elias AD; Finberg RW; Nadler LM; Ritz J; Anderson KC
Transfusion; 1996 Sep; 36(9):782-8. PubMed ID: 8823450
[TBL] [Abstract][Full Text] [Related]
2. Bacterial contamination of autologous bone marrow: reinfusion of culture-positive grafts does not result in clinical sequelae during the posttransplantation course.
Schwella N; Rick O; Heuft HG; Miksits K; Zimmermann R; Zingsem J; Eckstein R; Huhn D
Vox Sang; 1998; 74(2):88-94. PubMed ID: 9501406
[TBL] [Abstract][Full Text] [Related]
3. Microbiologic contamination of peripheral blood progenitor cells collected for hematopoietic cell transplantation.
Espinosa MT; Fox R; Creger RJ; Lazarus HM
Transfusion; 1996 Sep; 36(9):789-93. PubMed ID: 8823451
[TBL] [Abstract][Full Text] [Related]
4. Double T cell depletion of bone marrow using sequential positive and negative cell immunoaffinity or CD34+ cell selection followed by Campath-1M; effect on CD34+ cells and progenitor cell recoveries.
Clarke E; Potter MN; Hale G; Waldmann H; Lankester A; Cornish JM; Steward CG; Marks DI; Oakhill A; Pamphilon DH
Bone Marrow Transplant; 1998 Jul; 22(2):117-24. PubMed ID: 9707017
[TBL] [Abstract][Full Text] [Related]
5. Assessment of distribution of CD34 epitope classes in fresh and cryopreserved peripheral blood progenitor cells and acute myeloid leukemic blasts.
Lanza F; Moretti S; Castagnari B; Montanelli F; Latorraca A; Ferrari L; Bardi A; Dominici M; Campioni D; Dabusti M; Piva N; Lodi G; Reverberi R; Castoldi G
Haematologica; 1999 Nov; 84(11):969-77. PubMed ID: 10553156
[TBL] [Abstract][Full Text] [Related]
6. Influence of harvest bacterial contamination on autologous peripheral blood progenitor cells post-transplant.
Majado MJ; García-Hernández A; Morales A; González C; Martínez-Sánchez V; Menasalvas A; Rosique P; Rubio A; Sanz-Imedio E
Bone Marrow Transplant; 2007 Jan; 39(2):121-5. PubMed ID: 17173054
[TBL] [Abstract][Full Text] [Related]
7. A comparison of postengraftment infectious morbidity and mortality after allogeneic partially T cell-depleted peripheral blood progenitor cell transplantation versus T cell-depleted bone marrow transplantation.
Broers AE; van der Holt B; Haze S; Braakman E; Gratama JW; Löwenberg B; Cornelissen JJ
Exp Hematol; 2005 Aug; 33(8):912-9. PubMed ID: 16038784
[TBL] [Abstract][Full Text] [Related]
8. G-CSF-mobilized peripheral blood progenitor cells for allogeneic transplantation: comparison of T cell depletion strategies using different CD34+ selection systems or CAMPATH-1.
Dreger P; Viehmann K; Steinmann J; Eckstein V; Müller-Ruchholtz W; Löffler H; Schmitz N
Exp Hematol; 1995 Feb; 23(2):147-54. PubMed ID: 7530212
[TBL] [Abstract][Full Text] [Related]
9. CD34(+) hematopoietic progenitor cell selection of bone marrow grafts for autologous transplantation in pediatric patients.
Kasow KA; Sims-Poston L; Eldridge P; Hale GA
Biol Blood Marrow Transplant; 2007 May; 13(5):608-14. PubMed ID: 17448921
[TBL] [Abstract][Full Text] [Related]
10. Transplantation of enriched CD34-positive autologous marrow into breast cancer patients following high-dose chemotherapy: influence of CD34-positive peripheral-blood progenitors and growth factors on engraftment.
Shpall EJ; Jones RB; Bearman SI; Franklin WA; Archer PG; Curiel T; Bitter M; Claman HN; Stemmer SM; Purdy M
J Clin Oncol; 1994 Jan; 12(1):28-36. PubMed ID: 7505806
[TBL] [Abstract][Full Text] [Related]
11. Microbial contamination of hematopoietic progenitor and other regenerative cells used in transplantation and regenerative medicine.
Jacobs MR; Good CE; Fox RM; Roman KP; Lazarus HM
Transfusion; 2013 Nov; 53(11):2690-6. PubMed ID: 23461309
[TBL] [Abstract][Full Text] [Related]
12. Cryopreservation and mycophenolate therapy are detrimental to hematopoietic progenitor cells.
Bühler L; Kurilla-Mahon B; Chang Q; Abraham S; Alwayn IP; Appel JZ; Newman D; Awwad M; White-Scharf ME; Sackstein R; Sachs DH; Cooper DK; Down JD
Transplantation; 2002 Oct; 74(8):1159-66. PubMed ID: 12438964
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of hematological reconstitution potential of autologous peripheral blood progenitor cells cryopreserved by a simple controlled-rate freezing method.
Kudo Y; Minegishi M; Itoh T; Miura J; Saito N; Takahashi H; Suzuki A; Narita A; Sato Y; Kameoka J; Imaizumi M; Sato M; Murakawa Y; Tsuchiya S
Tohoku J Exp Med; 2005 Jan; 205(1):37-43. PubMed ID: 15635272
[TBL] [Abstract][Full Text] [Related]
14. Hematologic recovery after autologous PBPC transplantation: importance of the number of postthaw CD34+ cells.
Feugier P; Bensoussan D; Girard F; Alla F; Schuhmacher A; Latger-Cannard V; Hulin C; Witz F; Witz B; Carret AS; Bordigoni P; Lederlin P; Janot C
Transfusion; 2003 Jul; 43(7):878-84. PubMed ID: 12823747
[TBL] [Abstract][Full Text] [Related]
15. Peripheral blood and BM CD34+ CD38- cells show better resistance to cryopreservation than CD34+ CD38+ cells in autologous stem cell transplantation.
Ojeda-Uribe M; Sovalat H; Bourderont D; Brunot A; Marr A; Lewandowski H; Chabouté V; Peter P; Henon P
Cytotherapy; 2004; 6(6):571-83. PubMed ID: 15764022
[TBL] [Abstract][Full Text] [Related]
16. Quantitative lymphocyte subset reconstitution after allogeneic hematopoietic transplantation from matched related donors with CD34+ selected PBPC grafts unselected PBPC grafts or BM grafts.
Behringer D; Bertz H; Schmoor C; Berger C; Dwenger A; Finke J
Bone Marrow Transplant; 1999 Aug; 24(3):295-302. PubMed ID: 10455369
[TBL] [Abstract][Full Text] [Related]
17. Combined bone marrow and peripheral blood progenitor cell autografts for patients with poor mobilization.
Sinitsyn Y; Malone A; Mandeli J; Grosskreutz C; Osman K; Scigliano E; Shi P; Isola L
Cytotherapy; 2009; 11(4):457-63. PubMed ID: 19499401
[TBL] [Abstract][Full Text] [Related]
18. Comparison between bone marrow and G-CSF-mobilized peripheral blood allografts undergoing clinical scale CD34+ cell selection.
Hassan HT; Zeller W; Stockschläder M; Krüger W; Hoffknecht MM; Zander AR
Stem Cells; 1996 Jul; 14(4):419-29. PubMed ID: 8843543
[TBL] [Abstract][Full Text] [Related]
19. Microbial contamination of peripheral blood and bone marrow hematopoietic cell products and environmental contamination in a stem cell bank: a single-center report.
Kozlowska-Skrzypczak M; Bembnista E; Kubiak A; Matuszak P; Schneider A; Komarnicki M
Transplant Proc; 2014 Oct; 46(8):2873-6. PubMed ID: 25380939
[TBL] [Abstract][Full Text] [Related]
20. Single leukapheresis products collected from healthy donors after the administration of granulocyte colony-stimulating factor contain ten-fold higher numbers of long-term reconstituting hematopoietic progenitor cells than conventional bone marrow allografts.
Theilgaard-Mönch K; Raaschou-Jensen K; Andersen H; Russell CA; Vindeløv L; Jacobsen N; Dickmeiss E
Bone Marrow Transplant; 1999 Feb; 23(3):243-9. PubMed ID: 10084255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
